Crossmark

Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement

Crossref DOI link: https://doi.org/10.1038/gim.2016.221

Published Print: 2017-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Stark, Zornitza

Schofield, Deborah

Alam, Khurshid

Wilson, William

Mupfeki, Nessie

Macciocca, Ivan

Shrestha, Rupendra

White, Susan M.

Gaff, Clara
License Information

Text and Data Mining valid from 2017-08-01

Version of Record valid from 2022-01-19
More Information

This article is maintained by: Elsevier

Article Title: Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement

Journal Title: Genetics in Medicine

CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/gim.2016.221

Content Type: article

Copyright: © 2017, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics

Document is current

Any future updates will be listed below